Diagnosis and treatment of mycoplasmal septic arthritis: a systematic review
- 17 Downloads
Septic arthritis caused by Mycoplasma is rare. The diagnosis and effective treatment of mycoplasmal septic arthritis remains a serious problem for clinicians. The aim of this systematic review was to document the available evidence on the diagnosis and treatment methods for mycoplasmal septic arthritis and to provide guidance for clinicians.
The PubMed, EMBASE, and Cochrane Library databases were searched in December 2018.The searches were limited to the English language. Article screening and data extraction and compilation were conducted by two independent reviewers. All the included studies were assessed using the Methodological Index for Non-randomized Studies (MINORS) tool.
There was a total of 33 articles including 34 cases of mycoplasmal septic arthritis and eight of them were periprosthetic joint infection (PJI). Twenty-four patients (70.6%) were immunocompromised, and the synovial fluid white blood cell (WBC) count was significantly lower in the immunocompromised group than in the immunocompetent group (48,527 × 106/L vs. 100,640 × 106/L; P = 0.009). The traditional culture method took longer, and the positivity rate was lower than that of nucleic acid testing (50% vs. 100%; P = 0.016). Only 19.2% (5/26) of patients treated with empiric antibiotics were relieved of symptoms, while 82.4% (28/34) of patients achieved satisfactory results after being treated with antibiotics against Mycoplasma.
The possibility of mycoplasmal septic arthritis should be considered if patients with joint infections have a history of immunocompromised, repeated negative cultures, and poor empiric antibiotic treatment results. The rational use of nucleic acid testing technologies can help in the clinical diagnosis and treatment of mycoplasmal septic arthritis.
KeywordsMycoplasmal septic arthritis Periprosthetic joint infection Immunocompromise Nucleic acid testing
This paper is supported by Natural Science Foundation of Fujian Province (grant numbers 2018I0006, 2019I0011, and 2018Y4003).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 10.van Doornum GJ, Schutten M, Voermans J, Guldemeester GJ, Niesters HG (2007) Development and implementation of real-time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens. J Med Virol 79:1868–1876. https://doi.org/10.1002/jmv.21031 CrossRefPubMedGoogle Scholar
- 13.Thoendel M, Jeraldo P, Greenwood-Quaintance KE, Chia N, Abdel MP, Steckelberg JM, Osmon DR, Patel R (2017) A novel prosthetic joint infection pathogen, Mycoplasma salivarium, identified by metagenomic shotgun sequencing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65:332–335. https://doi.org/10.1093/cid/cix296 CrossRefGoogle Scholar
- 14.Buchsel M, Pletschen L, Fleiner M, Hacker G, Serr A (2016) A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards ciprofloxacin and clarithromycin in a patient with chronic lymphatic leukemia. Diagn Microbiol Infect Dis 86:115–117. https://doi.org/10.1016/j.diagmicrobio.2016.05.018 CrossRefPubMedGoogle Scholar
- 18.Sato H, Iino N, Ohashi R, Saeki T, Ito T, Saito M, Tsubata Y, Yamamoto S, Murakami S, Kuroda T, Tanabe Y, Fujisawa J, Murai T, Nakano M, Narita I, Gejyo F (2012) Hypogammaglobulinemic patient with polyarthritis mimicking rheumatoid arthritis finally diagnosed as septic arthritis caused by Mycoplasma hominis. Intern Med 51:425–429. https://doi.org/10.2169/internalmedicine.51.6058 CrossRefPubMedGoogle Scholar
- 22.MacKenzie CR, Nischik N, Kram R, Krauspe R, Jager M, Henrich B (2010) Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient. Int J Infect Dis 14(Suppl 3):e307–e309. https://doi.org/10.1016/j.ijid.2010.02.2253 CrossRefPubMedGoogle Scholar
- 24.Mian AN, Farney AC, Mendley SR (2005) Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 5:183–188. https://doi.org/10.1111/j.1600-6143.2004.00634.x CrossRefGoogle Scholar
- 34.Clough W, Cassell GH, Duffy LB, Rinaldi RZ, Bluestone R, Morgan MA, Meyer RD (1992) Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus. Clin Infect Dis 15:402–407. https://doi.org/10.1093/clind/15.3.402 CrossRefPubMedGoogle Scholar
- 35.Lehmer RR, Andrews BS, Robertson JA, Stanbridge EJ, de la Maza L, Friou GJ (1991) Clinical and biological characteristics of Ureaplasma urealyticum induced polyarthritis in a patient with common variable hypogammaglobulinaemia. Ann Rheum Dis 50:574–576. https://doi.org/10.1136/ard.50.8.574 CrossRefPubMedPubMedCentralGoogle Scholar
- 38.SK K (1988) Mycoplasma hominis septic arthritis. Ann Plast Surg 20:163–166Google Scholar
- 41.Johnston CL, Webster AD, Taylor-Robinson D, Rapaport G, Hughes GR (1983) Primary late-onset hypogammaglobulinaemia associated with inflammatory polyarthritis and septic arthritis due to Mycoplasma pneumoniae. Ann Rheum Dis 42:108–110. https://doi.org/10.1136/ard.42.1.108 CrossRefPubMedPubMedCentralGoogle Scholar
- 50.Ferrarini MG, Siqueira FM, Mucha SG, Palama TL, Jobard E, Elena-Herrmann B, V ATR, Tardy F, Schrank IS, Zaha A, Sagot MF (2016) Insights on the virulence of swine respiratory tract mycoplasmas through genome-scale metabolic modeling. BMC Genomics 17:353. https://doi.org/10.1186/s12864-016-2644-z CrossRefPubMedPubMedCentralGoogle Scholar
- 55.Kessler HHDD, Pierer K, Young KK, Liao Y, Santner BI, Eber E, Roeger MG, Stuenzner D, Sixl-Voigt B, Marth E (1997) Rapid detection of Mycoplasma pneumoniae by an assay based on PCR and probe hybridization in a nonradioactive microwell plate format. J Clin Microbiol 35:1592–1594PubMedPubMedCentralGoogle Scholar
- 56.Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer ML, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothberg JM (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376–380. https://doi.org/10.1038/nature03959 CrossRefPubMedPubMedCentralGoogle Scholar
- 57.Pendleton KM, Erb-Downward JR, Bao Y, Branton WR, Falkowski NR, Newton DW, Huffnagle GB, Dickson RP (2017) Rapid pathogen identification in bacterial pneumonia using real-time metagenomics. Am J Respir Crit Care Med 196:1610–1612. https://doi.org/10.1164/rccm.201703-0537LE CrossRefPubMedPubMedCentralGoogle Scholar
- 58.Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW (2014) Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 12:87. https://doi.org/10.1186/s12915-014-0087-z CrossRefPubMedPubMedCentralGoogle Scholar
- 60.Kasprzykowska U, Sobieszczanska B, Duda-Madej A, Secewicz A, Nowicka J, Gosciniak G (2018) A twelve-year retrospective analysis of prevalence and antimicrobial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of Lower Silesia in Poland. Eur J Obstet Gynecol Reprod Biol 220:44–49. https://doi.org/10.1016/j.ejogrb.2017.11.010 CrossRefPubMedGoogle Scholar
- 61.Pereyre S, Gonzalez P, De Barbeyrac B, Darnige A, Renaudin H, Charron A, Raherison S, Bebear C, Bebear CM (2002) Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob Agents Chemother 46:3142–3150. https://doi.org/10.1128/aac.46.10.3142-3150.2002 CrossRefPubMedPubMedCentralGoogle Scholar
- 62.Nummi M, Mannonen L, Puolakkainen M (2015) Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae, Chlamydia pneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens. SpringerPlus 4:684. https://doi.org/10.1186/s40064-015-1457-x CrossRefPubMedPubMedCentralGoogle Scholar
- 65.Krausse R, Schubert S (2010) In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 16:1649–1655. https://doi.org/10.1111/j.1469-0691.2009.03155.x CrossRefPubMedGoogle Scholar
- 69.Prendki V, Ferry T, Sergent P, Oziol E, Forestier E, Fraisse T, Tounes S, Ansart S, Gaillat J, Bayle S, Ruyer O, Borlot F, Le Falher G, Simorre B, Dauchy FA, Greffe S, Bauer T, Bell EN, Martha B, Martinot M, Froidure M, Buisson M, Waldner A, Lemaire X, Bosseray A, Maillet M, Charvet V, Barrelet A, Wyplosz B, Noaillon M, Denes E, Beretti E, Berlioz-Thibal M, Meyssonnier V, Fourniols E, Tliba L, Eden A, Jean M, Arvieux C, Guignery-Kadri K, Ronde-Oustau C, Hansmann Y, Belkacem A, Bouchand F, Gavazzi G, Herrmann F, Stirnemann J, Dinh A (2017) Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study. Eur J Clin Microbiol Infect Dis 36:1577–1585. https://doi.org/10.1007/s10096-017-2971-2 CrossRefPubMedGoogle Scholar